India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
China has launched the Shenzhou 23 spacecraft and sent the three astronauts to its Tiangong…
For the year 2026, the Sansad Ratna Awards have been announced the outstanding performance by…
As the IPL now at the climax part, final 4 teams are now officially confirmed…
Football Icon Lionel Messi has officially enters to the billionaire club and become the only…
Rajya Sabha MP Raghav Chadha has been appointed as the new Chairman of the Rajya…
Major Abhilasha Barak who was serving with the United Nations peacekeeping mission in Lebanon has…